Global External Neuromodulation Market Research Report 2023

The global External Neuromodulation market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for External Neuromodulation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for External Neuromodulation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for External Neuromodulation in Spinal Cord Stimulation is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of External Neuromodulation include Medtronic, Inc. (US), Boston Scientific Corporation (US), St. Jude Medical, Inc. (US), Synapse Biomedical, Inc. (US), Nevro Corporation (US), Neurosigma, Inc. (US), Neuropace, Inc. (US), Neuronetics, Inc. (US) and Cyberonics, Inc. (US), etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for External Neuromodulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding External Neuromodulation.

The External Neuromodulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global External Neuromodulation market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the External Neuromodulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global External Neuromodulation Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Transcutaneous Electrical Nerve Stimulation

1.2.3 Transcranial Magnetic Stimulation

1.2.4 Respiratory Electrical Stimulation

1.3 Market by Application

1.3.1 Global External Neuromodulation Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Spinal Cord Stimulation

1.3.3 Deep Brain Stimulation

1.3.4 Sacral Nerve Stimulation

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global External Neuromodulation Market Perspective (2018-2029)

2.2 External Neuromodulation Growth Trends by Region

2.2.1 Global External Neuromodulation Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 External Neuromodulation Historic Market Size by Region (2018-2023)

2.2.3 External Neuromodulation Forecasted Market Size by Region (2024-2029)

2.3 External Neuromodulation Market Dynamics

2.3.1 External Neuromodulation Industry Trends

2.3.2 External Neuromodulation Market Drivers

2.3.3 External Neuromodulation Market Challenges

2.3.4 External Neuromodulation Market Restraints

3.1 Global Top External Neuromodulation Players by Revenue

3.1.1 Global Top External Neuromodulation Players by Revenue (2018-2023)

3.1.2 Global External Neuromodulation Revenue Market Share by Players (2018-2023)

3.2 Global External Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by External Neuromodulation Revenue

3.4 Global External Neuromodulation Market Concentration Ratio

3.4.1 Global External Neuromodulation Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by External Neuromodulation Revenue in 2022

3.5 External Neuromodulation Key Players Head office and Area Served

3.6 Key Players External Neuromodulation Product Solution and Service

3.7 Date of Enter into External Neuromodulation Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global External Neuromodulation Historic Market Size by Type (2018-2023)

4.2 Global External Neuromodulation Forecasted Market Size by Type (2024-2029)

5.1 Global External Neuromodulation Historic Market Size by Application (2018-2023)

5.2 Global External Neuromodulation Forecasted Market Size by Application (2024-2029)

6.1 North America External Neuromodulation Market Size (2018-2029)

6.2 North America External Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America External Neuromodulation Market Size by Country (2018-2023)

6.4 North America External Neuromodulation Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe External Neuromodulation Market Size (2018-2029)

7.2 Europe External Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe External Neuromodulation Market Size by Country (2018-2023)

7.4 Europe External Neuromodulation Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific External Neuromodulation Market Size (2018-2029)

8.2 Asia-Pacific External Neuromodulation Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific External Neuromodulation Market Size by Region (2018-2023)

8.4 Asia-Pacific External Neuromodulation Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America External Neuromodulation Market Size (2018-2029)

9.2 Latin America External Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America External Neuromodulation Market Size by Country (2018-2023)

9.4 Latin America External Neuromodulation Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa External Neuromodulation Market Size (2018-2029)

10.2 Middle East & Africa External Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa External Neuromodulation Market Size by Country (2018-2023)

10.4 Middle East & Africa External Neuromodulation Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Medtronic, Inc. (US)

11.1.1 Medtronic, Inc. (US) Company Detail

11.1.2 Medtronic, Inc. (US) Business Overview

11.1.3 Medtronic, Inc. (US) External Neuromodulation Introduction

11.1.4 Medtronic, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)

11.1.5 Medtronic, Inc. (US) Recent Development

11.2 Boston Scientific Corporation (US)

11.2.1 Boston Scientific Corporation (US) Company Detail

11.2.2 Boston Scientific Corporation (US) Business Overview

11.2.3 Boston Scientific Corporation (US) External Neuromodulation Introduction

11.2.4 Boston Scientific Corporation (US) Revenue in External Neuromodulation Business (2018-2023)

11.2.5 Boston Scientific Corporation (US) Recent Development

11.3 St. Jude Medical, Inc. (US)

11.3.1 St. Jude Medical, Inc. (US) Company Detail

11.3.2 St. Jude Medical, Inc. (US) Business Overview

11.3.3 St. Jude Medical, Inc. (US) External Neuromodulation Introduction

11.3.4 St. Jude Medical, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)

11.3.5 St. Jude Medical, Inc. (US) Recent Development

11.4 Synapse Biomedical, Inc. (US)

11.4.1 Synapse Biomedical, Inc. (US) Company Detail

11.4.2 Synapse Biomedical, Inc. (US) Business Overview

11.4.3 Synapse Biomedical, Inc. (US) External Neuromodulation Introduction

11.4.4 Synapse Biomedical, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)

11.4.5 Synapse Biomedical, Inc. (US) Recent Development

11.5 Nevro Corporation (US)

11.5.1 Nevro Corporation (US) Company Detail

11.5.2 Nevro Corporation (US) Business Overview

11.5.3 Nevro Corporation (US) External Neuromodulation Introduction

11.5.4 Nevro Corporation (US) Revenue in External Neuromodulation Business (2018-2023)

11.5.5 Nevro Corporation (US) Recent Development

11.6 Neurosigma, Inc. (US)

11.6.1 Neurosigma, Inc. (US) Company Detail

11.6.2 Neurosigma, Inc. (US) Business Overview

11.6.3 Neurosigma, Inc. (US) External Neuromodulation Introduction

11.6.4 Neurosigma, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)

11.6.5 Neurosigma, Inc. (US) Recent Development

11.7 Neuropace, Inc. (US)

11.7.1 Neuropace, Inc. (US) Company Detail

11.7.2 Neuropace, Inc. (US) Business Overview

11.7.3 Neuropace, Inc. (US) External Neuromodulation Introduction

11.7.4 Neuropace, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)

11.7.5 Neuropace, Inc. (US) Recent Development

11.8 Neuronetics, Inc. (US)

11.8.1 Neuronetics, Inc. (US) Company Detail

11.8.2 Neuronetics, Inc. (US) Business Overview

11.8.3 Neuronetics, Inc. (US) External Neuromodulation Introduction

11.8.4 Neuronetics, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)

11.8.5 Neuronetics, Inc. (US) Recent Development

11.9 Cyberonics, Inc. (US)

11.9.1 Cyberonics, Inc. (US) Company Detail

11.9.2 Cyberonics, Inc. (US) Business Overview

11.9.3 Cyberonics, Inc. (US) External Neuromodulation Introduction

11.9.4 Cyberonics, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)

11.9.5 Cyberonics, Inc. (US) Recent Development

11.10 BioControl Medical (Israel)

11.10.1 BioControl Medical (Israel) Company Detail

11.10.2 BioControl Medical (Israel) Business Overview

11.10.3 BioControl Medical (Israel) External Neuromodulation Introduction

11.10.4 BioControl Medical (Israel) Revenue in External Neuromodulation Business (2018-2023)

11.10.5 BioControl Medical (Israel) Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global External Neuromodulation Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Transcutaneous Electrical Nerve Stimulation

    Table 3. Key Players of Transcranial Magnetic Stimulation

    Table 4. Key Players of Respiratory Electrical Stimulation

    Table 5. Global External Neuromodulation Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global External Neuromodulation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global External Neuromodulation Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global External Neuromodulation Market Share by Region (2018-2023)

    Table 9. Global External Neuromodulation Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global External Neuromodulation Market Share by Region (2024-2029)

    Table 11. External Neuromodulation Market Trends

    Table 12. External Neuromodulation Market Drivers

    Table 13. External Neuromodulation Market Challenges

    Table 14. External Neuromodulation Market Restraints

    Table 15. Global External Neuromodulation Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global External Neuromodulation Market Share by Players (2018-2023)

    Table 17. Global Top External Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in External Neuromodulation as of 2022)

    Table 18. Ranking of Global Top External Neuromodulation Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by External Neuromodulation Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players External Neuromodulation Product Solution and Service

    Table 22. Date of Enter into External Neuromodulation Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global External Neuromodulation Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global External Neuromodulation Revenue Market Share by Type (2018-2023)

    Table 26. Global External Neuromodulation Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global External Neuromodulation Revenue Market Share by Type (2024-2029)

    Table 28. Global External Neuromodulation Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global External Neuromodulation Revenue Market Share by Application (2018-2023)

    Table 30. Global External Neuromodulation Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global External Neuromodulation Revenue Market Share by Application (2024-2029)

    Table 32. North America External Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America External Neuromodulation Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America External Neuromodulation Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe External Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe External Neuromodulation Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe External Neuromodulation Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific External Neuromodulation Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific External Neuromodulation Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific External Neuromodulation Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America External Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America External Neuromodulation Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America External Neuromodulation Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa External Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa External Neuromodulation Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa External Neuromodulation Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Medtronic, Inc. (US) Company Detail

    Table 48. Medtronic, Inc. (US) Business Overview

    Table 49. Medtronic, Inc. (US) External Neuromodulation Product

    Table 50. Medtronic, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)

    Table 51. Medtronic, Inc. (US) Recent Development

    Table 52. Boston Scientific Corporation (US) Company Detail

    Table 53. Boston Scientific Corporation (US) Business Overview

    Table 54. Boston Scientific Corporation (US) External Neuromodulation Product

    Table 55. Boston Scientific Corporation (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)

    Table 56. Boston Scientific Corporation (US) Recent Development

    Table 57. St. Jude Medical, Inc. (US) Company Detail

    Table 58. St. Jude Medical, Inc. (US) Business Overview

    Table 59. St. Jude Medical, Inc. (US) External Neuromodulation Product

    Table 60. St. Jude Medical, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)

    Table 61. St. Jude Medical, Inc. (US) Recent Development

    Table 62. Synapse Biomedical, Inc. (US) Company Detail

    Table 63. Synapse Biomedical, Inc. (US) Business Overview

    Table 64. Synapse Biomedical, Inc. (US) External Neuromodulation Product

    Table 65. Synapse Biomedical, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)

    Table 66. Synapse Biomedical, Inc. (US) Recent Development

    Table 67. Nevro Corporation (US) Company Detail

    Table 68. Nevro Corporation (US) Business Overview

    Table 69. Nevro Corporation (US) External Neuromodulation Product

    Table 70. Nevro Corporation (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)

    Table 71. Nevro Corporation (US) Recent Development

    Table 72. Neurosigma, Inc. (US) Company Detail

    Table 73. Neurosigma, Inc. (US) Business Overview

    Table 74. Neurosigma, Inc. (US) External Neuromodulation Product

    Table 75. Neurosigma, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)

    Table 76. Neurosigma, Inc. (US) Recent Development

    Table 77. Neuropace, Inc. (US) Company Detail

    Table 78. Neuropace, Inc. (US) Business Overview

    Table 79. Neuropace, Inc. (US) External Neuromodulation Product

    Table 80. Neuropace, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)

    Table 81. Neuropace, Inc. (US) Recent Development

    Table 82. Neuronetics, Inc. (US) Company Detail

    Table 83. Neuronetics, Inc. (US) Business Overview

    Table 84. Neuronetics, Inc. (US) External Neuromodulation Product

    Table 85. Neuronetics, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)

    Table 86. Neuronetics, Inc. (US) Recent Development

    Table 87. Cyberonics, Inc. (US) Company Detail

    Table 88. Cyberonics, Inc. (US) Business Overview

    Table 89. Cyberonics, Inc. (US) External Neuromodulation Product

    Table 90. Cyberonics, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)

    Table 91. Cyberonics, Inc. (US) Recent Development

    Table 92. BioControl Medical (Israel) Company Detail

    Table 93. BioControl Medical (Israel) Business Overview

    Table 94. BioControl Medical (Israel) External Neuromodulation Product

    Table 95. BioControl Medical (Israel) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)

    Table 96. BioControl Medical (Israel) Recent Development

    Table 97. Research Programs/Design for This Report

    Table 98. Key Data Information from Secondary Sources

    Table 99. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global External Neuromodulation Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global External Neuromodulation Market Share by Type: 2022 VS 2029

    Figure 3. Transcutaneous Electrical Nerve Stimulation Features

    Figure 4. Transcranial Magnetic Stimulation Features

    Figure 5. Respiratory Electrical Stimulation Features

    Figure 6. Global External Neuromodulation Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global External Neuromodulation Market Share by Application: 2022 VS 2029

    Figure 8. Spinal Cord Stimulation Case Studies

    Figure 9. Deep Brain Stimulation Case Studies

    Figure 10. Sacral Nerve Stimulation Case Studies

    Figure 11. Others Case Studies

    Figure 12. External Neuromodulation Report Years Considered

    Figure 13. Global External Neuromodulation Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global External Neuromodulation Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global External Neuromodulation Market Share by Region: 2022 VS 2029

    Figure 16. Global External Neuromodulation Market Share by Players in 2022

    Figure 17. Global Top External Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in External Neuromodulation as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by External Neuromodulation Revenue in 2022

    Figure 19. North America External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America External Neuromodulation Market Share by Country (2018-2029)

    Figure 21. United States External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe External Neuromodulation Market Share by Country (2018-2029)

    Figure 25. Germany External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific External Neuromodulation Market Share by Region (2018-2029)

    Figure 33. China External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America External Neuromodulation Market Share by Country (2018-2029)

    Figure 41. Mexico External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa External Neuromodulation Market Share by Country (2018-2029)

    Figure 45. Turkey External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Medtronic, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)

    Figure 48. Boston Scientific Corporation (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)

    Figure 49. St. Jude Medical, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)

    Figure 50. Synapse Biomedical, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)

    Figure 51. Nevro Corporation (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)

    Figure 52. Neurosigma, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)

    Figure 53. Neuropace, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)

    Figure 54. Neuronetics, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)

    Figure 55. Cyberonics, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)

    Figure 56. BioControl Medical (Israel) Revenue Growth Rate in External Neuromodulation Business (2018-2023)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed